BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32103551)

  • 1. A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.
    Sekine I; Shintani Y; Shukuya T; Takayama K; Inoue A; Okamoto I; Kiura K; Takahashi K; Dosaka-Akita H; Takiguchi Y; Miyaoka E; Okumura M; Yoshino I
    Cancer Sci; 2020 May; 111(5):1685-1691. PubMed ID: 32103551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
    Goya T; Asamura H; Yoshimura H; Kato H; Shimokata K; Tsuchiya R; Sohara Y; Miya T; Miyaoka E;
    Lung Cancer; 2005 Nov; 50(2):227-34. PubMed ID: 16061304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients].
    Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
    Okami J; Shintani Y; Okumura M; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Date H; Yokoi K; Asamura H; Nagayasu T; Miyaoka E; Yoshino I;
    J Thorac Oncol; 2019 Feb; 14(2):212-222. PubMed ID: 30316011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
    Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Shimokata K; Inoue H; Nukiwa T; Miyaoka E;
    J Thorac Oncol; 2008 Jan; 3(1):46-52. PubMed ID: 18166840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non-small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation.
    Qiu B; Liang Y; Li Q; Liu G; Wang F; Chen Z; Liu M; Zhao M; Liu H
    Clin Lung Cancer; 2017 Nov; 18(6):e369-e373. PubMed ID: 28465010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
    Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
    J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
    Morgan E; Arnold M; Rutherford MJ; Bardot A; Ferlay J; De P; Engholm G; Jackson C; Little A; Saint-Jacques N; Walsh P; Woods RR; O'Connell DL; Bray F; Parkin DM; Soerjomataram I
    Int J Cancer; 2021 Sep; 149(5):1013-1020. PubMed ID: 33932300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.
    Naruke T; Tsuchiya R; Kondo H; Asamura H
    Ann Thorac Surg; 2001 Jun; 71(6):1759-64. PubMed ID: 11426744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
    Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
    Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations.
    Zheng L; Wang Y; Xu Z; Yang Q; Zhu G; Liao XY; Chen X; Zhu B; Duan Y; Sun J
    Oncologist; 2019 Aug; 24(8):1031-e612. PubMed ID: 31040256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer in Victoria: are we making progress?
    Mitchell PL; Thursfield VJ; Ball DL; Richardson GE; Irving LB; Torn-Broers Y; Giles GG; Wright GM
    Med J Aust; 2013 Nov; 199(10):674-9. PubMed ID: 24237097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
    Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
    BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.
    Driessen EJM; Schulkes KJG; Dingemans AC; van Loon JGM; Hamaker ME; Aarts MJ; Janssen-Heijnen MLG
    Lung Cancer; 2018 Feb; 116():55-61. PubMed ID: 29413051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade.
    Sawabata N; Miyaoka E; Asamura H; Nakanishi Y; Eguchi K; Mori M; Nomori H; Fujii Y; Okumura M; Yokoi K;
    J Thorac Oncol; 2011 Jul; 6(7):1229-35. PubMed ID: 21610521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
    Aiko N; Shimokawa T; Miyazaki K; Misumi Y; Agemi Y; Ishii M; Nakamura Y; Yamanaka T; Okamoto H
    BMC Cancer; 2018 Oct; 18(1):1012. PubMed ID: 30348116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
    Xu L; Zhang G; Song S; Zheng Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.